wide angle implantable miniature telescope
visioncare ophthalmic technologies ltd. - רופא - the imt(by dr. isaac lipshitz) is indicated for improvement of visual acuity in patients with bilateral moderate to profound central vision impairment due to age-related macular degeneration
laryngeal airways and accessories for anaesthesia
מסטמן מדיקל - רופא - the devices are intended for use by anaesthesiologists in order to create and maintain a patent airway during anaesthesia. the devices come in 7 sizes to suit all patients in which use of a laryngeal airway is indicated. the single-use device is marketed under the trade name ‘lapremiere plus’ and is supplied sterile. the reusable device is marketed under the trade name ‘laencore plus’ and is supplied non-sterile for reprocessing and sterilization by the user. these devices are accompanied by accessories to aid placement and fixation.
dialyzers
טבע מדיקל (שיווק) בע"מ - אחות - indicated for patients having acute renal failure when dialysis is prescribed by the physician
spinal cord stimulation systems
מדוגר מכשור רפואי בע"מ - מומחה - sjm systems are indicated for spinal cord stimulation in the treatment of chronic pain of the trunk and limbs, and chronic migraine by peripheral nerve stimulation
navigo workstation
uc-care ltd. - רופא - the uc-care navigotm workstation is intended to be used by physicians in the clinic or hospital for 2-d and 3-d visualization of ultrasound images of the prostate gland. additional software features assist biopsy procedures include patient data management, multi-planar reconstruction, segmentation, image measurement and 3-d image registration. the device is specifically indicated for reconstruction of a 3d rendered surface model of the prostate and to display locations for biopsies that have been selected by the physician, as well as storage and future retrieval of this information. the expected system accuracy is ±5 mm. this includes the accuracy of the prostate surface that is presented to the practitioner over the navigotm workstation screen during 3d model reconstructions and also the accuracy of the biopsy needle trajectory that is presented to the practitioner over the navigotm workstation screen during the biopsy session. all clinical decisions taken regarding the use of the uc-care navigo™ workstation
זיקאדיה 150 מג
novartis israel ltd - ceritinib - קפסולות ג'לטין קשיחות - ceritinib 150 mg - ceritinib
בייאטה 5 מק"ג
astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.
בייאטה 5 מק"ג
astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.
בייאטה 10 מק"ג
astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.
בייאטה 10 מק"ג
astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.